Pathstone Holdings
BSX icon

Pathstone Holdings’s Boston Scientific BSX Stock Holding History

Pathstone Holdings’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.09M Buy
188,970
+8,628
+5% +$469K 0.02% 484
2026
Q1 		$11.3M Buy
180,342
+4,035
+2% +$323K 0.05% 305
2025
Q4 		$16.8M Buy
176,307
+28,016
+19% +$2.75M 0.06% 206
2025
Q3 		$14.5M Sell
148,291
-2,233
-1% -$231K 0.06% 233
2025
Q2 		$16.2M Buy
150,524
+11,627
+8% +$1.18M 0.06% 207
2025
Q1 		$14M Buy
138,897
+12,806
+10% +$1.29M 0.06% 242
2024
Q4 		$11.3M Buy
126,091
+1,659
+1% +$146K 0.05% 263
2024
Q3 		$10.4M Buy
124,432
+170
+0.1% +$13.4K 0.05% 308
2024
Q2 		$9.57M Buy
124,262
+7,398
+6% +$542K 0.04% 309
2024
Q1 		$8M Sell
116,864
-7,517
-6% -$483K 0.04% 374
2023
Q4 		$7.2M Buy
+124,381
New +$6.64M 0.04% 336

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pathstone Holdings's BSX Position: Q2 2026 in Review

Pathstone Holdings increased its Boston Scientific (BSX) stake by 4.8% in Q2 2026, buying an estimated $469K and bringing the position to 188,970 shares worth $8.09M. The position accounts for 0.02% of the portfolio, ranked #484.

Pathstone Holdings first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $16.8M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Pathstone Holdings held 188,970 shares of Boston Scientific worth $8.09M as of Q2 2026.
  • Pathstone Holdings bought 8,628 Boston Scientific shares in Q2 2026, an estimated $469K.
  • Boston Scientific made up 0.02% of Pathstone Holdings's portfolio in Q2 2026, its #484 holding.
  • Pathstone Holdings first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Boston Scientific position peaked at $16.8M in Q4 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.